A

Alto Neuroscience
D

ANRO

18.270
USD
-1.74
(-8.70%)
مغلق
حجم التداول
19,516
الربح لكل سهم
-3
العائد الربحي
-
P/E
-8
حجم السوق
641,166,284
المقالات
المزيد

العنوان: Alto Neuroscience

القطاع: Healthcare
الصناعة: Biotechnology
Alto Neuroscience Inc is a clinical-stage biopharmaceutical company with a mission to redefine psychiatry by leveraging individual's neurobiology to develop personalized and effective treatment options. The company currently consists of different clinical-stage assets such as ALTO-100, ALTO-202, ALTO-207, ALTO-101, and ALTO-300 among others initially targeting depressive disorders and schizophrenia populations as identified by independent brain-based biomarkers.